injection

Colistin-3 MIU Injection contains Colistimethate Sodium equivalent to Colistin (3 Million International Units), a potent polymyxin-class antibiotic used for the treatment of serious, life-threatening infections caused by multidrug-resistant (MDR) gram-negative bacteria. It is considered a last-line or reserve antibiotic, primarily used in hospital and intensive care settings (ICU) when other standard antibiotics such as carbapenems, cephalosporins, or aminoglycosides are ineffective. Colistin plays a critical role in modern infection management, especially for drug-resistant and hospital-acquired infections. Key Benefits ✔ Effective against multidrug-resistant pathogens ✔ Life-saving option in critical infections ✔ Rapid bactericidal action ✔ Suitable for ICU use ✔ Multiple routes of administration ✔ Reliable last-line therapy

Colistin (Polymyxin E) is a bactericidal antibiotic that works by disrupting the bacterial outer cell membrane, causing leakage of essential cell components and rapid bacterial death. COLICULT-1 Injection is formulated for parenteral administration and provides strong activity against difficult-to-treat gram-negative pathogens, especially those resistant to carbapenems, cephalosporins, and other antibiotics. Due to its potency, this medication is administered only under strict medical supervision, with careful monitoring of kidney and neurological functions. Uses (Indications) COLICULT-1 Injection is indicated for the treatment of severe infections caused by susceptible gram-negative bacteria, especially when other antibiotics fail. Common clinical uses include: ✅ Respiratory Tract Infections Hospital-acquired pneumonia Ventilator-associated pneumonia (VAP) ✅ Bloodstream Infections Septicemia Bacteremia ✅ Urinary Tract Infections Complicated UTIs Pyelonephritis ✅ Intra-abdominal Infections Peritonitis Post-surgical infections ✅ Skin & Soft Tissue Infections Wound infections Burns Surgical site infections ✅ Meningitis (selected cases) ✅ Multidrug-Resistant Infections Carbapenem-resistant infections ICU-related infections Nosocomial infections

CEFREST-S 1.5 INJ is a highly effective broad-spectrum antibiotic combination containing Ceftriaxone (1000 mg) and Sulbactam (500 mg). This advanced formulation provides enhanced antibacterial protection against a wide range of gram-positive, gram-negative, and beta-lactamase–producing bacteria. Designed for moderate to severe and resistant infections, CEFREST-S is widely used in hospitals, emergency care, and critical care settings where rapid and reliable treatment is essential. Mechanism of Action CEFREST-S works through a dual mechanism: Ceftriaxone: Inhibits bacterial cell wall formation Causes bacterial cell death Sulbactam: Inactivates beta-lactamase enzymes Prevents antibiotic breakdown

Ceftriaxone is a broad-spectrum beta-lactam antibiotic that effectively treats infections caused by both gram-positive and gram-negative bacteria. It is known for its long duration of action, which allows less frequent dosing while maintaining strong antibacterial activity. Indications (Uses) Ceftriaxone 1000 mg Injection is indicated for the treatment of various infections caused by susceptible organisms. Common indications include: ✅ Respiratory Tract Infections Pneumonia Bronchitis Lung infections ✅ Urinary Tract Infections Complicated and uncomplicated UTIs Pyelonephritis ✅ Skin & Soft Tissue Infections Cellulitis Wound infections Abscesses ✅ Intra-abdominal Infections Peritonitis Biliary tract infections ✅ Bone & Joint Infections Osteomyelitis Septic arthritis ✅ Bloodstream Infections Septicemia Bacteremia ✅ Meningitis Bacterial meningitis (adults and children) ✅ Sexually Transmitted Infections Gonorrhea Pelvic inflammatory disease ✅ Surgical Prophylaxis Prevention of postoperative infections

Cefoperazone 1000 mg + Sulbactam 500 mg Injection is a powerful combination antibiotic therapy designed to treat moderate to severe bacterial infections, including those caused by beta-lactamase–producing and multidrug-resistant organisms. Indications (Uses) This injection is indicated for the treatment of a wide range of infections caused by susceptible organisms, especially where resistance is suspected. Common indications include: ✅ Respiratory Tract Infections Pneumonia Bronchitis Lung abscess Hospital-acquired infections ✅ Urinary Tract Infections Complicated UTIs Pyelonephritis ✅ Intra-abdominal Infections Peritonitis Appendicitis Biliary tract infections Post-surgical infections ✅ Skin & Soft Tissue Infections Cellulitis Diabetic foot infections Wound and burn infections ✅ Gynecological & Pelvic Infections ✅ Bloodstream Infections Septicemia Bacteremia ✅ Bone & Joint Infections ✅ Surgical Prophylaxis

Cefoperazone is a semi-synthetic, broad-spectrum cephalosporin antibiotic that belongs to the beta-lactam class. It works by interfering with bacterial cell wall synthesis, leading to bacterial death. It is especially effective against gram-negative bacteria, including Pseudomonas aeruginosa, which makes it a preferred option in many serious infections. Use in Special Populations Pregnancy Use only if clearly necessary Breastfeeding Consult physician before use Pediatric Safe with dose adjustment Elderly Monitoring recommended

AMIWAR 500 (Amikacin 500 mg Injection) is a powerful aminoglycoside antibiotic used for the treatment of moderate to severe bacterial infections, particularly those caused by gram-negative and multidrug-resistant organisms. It is widely utilized in hospitals and critical care settings for its rapid bactericidal action and reliability against difficult-to-treat infections. Key Benefits of AMIWAR 500 ✔ Rapid bactericidal action ✔ Effective against resistant gram-negative bacteria ✔ Suitable for severe infections ✔ Synergistic effect with other antibiotics ✔ Reliable treatment option for complicated infections

AMIWAR 250 (Amikacin 250 mg Injection) is a powerful aminoglycoside antibiotic used for the treatment of moderate to severe bacterial infections, particularly those caused by gram-negative and multidrug-resistant organisms. It is widely utilized in hospitals and critical care settings for its rapid bactericidal action and reliability against difficult-to-treat infections. Key Benefits of AMIWAR 250 ✔ Rapid bactericidal action ✔ Effective against resistant gram-negative bacteria ✔ Suitable for severe infections ✔ Synergistic effect with other antibiotics ✔ Trusted in hospital and ICU settings ✔ Reliable treatment option for complicated infections

Tigecycline 50 mg Injection is a next-generation glycylcycline antibiotic designed for the treatment of complicated and life-threatening bacterial infections, particularly those caused by multidrug-resistant (MDR) organisms. Tigecycline is a semi-synthetic derivative of minocycline that overcomes many common bacterial resistance mechanisms, including: Efflux pumps Ribosomal protection Tetracycline resistance It is specifically developed to treat serious infections caused by resistant pathogens, including MRSA, VRE, and ESBL-producing bacteria. Key Benefits of Tigecycline Injection ✔ Broad-spectrum antibacterial coverage ✔ Effective against multidrug-resistant pathogens ✔ Useful in polymicrobial infections ✔ Excellent tissue penetration ✔ Ideal for complicated infections ✔ Option when other antibiotics fail ✔ Convenient IV dosing schedule

Teicoplanin Injection 400 mg is a potent glycopeptide antibiotic used for the treatment of severe and complicated gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant organisms. It is widely used in hospital and critical care settings due to its strong bactericidal activity, long half-life, and excellent safety profile. Key Benefits of Teicoplanin Injection ✔ Highly effective against MRSA ✔ Long half-life – once daily dosing ✔ Lower kidney toxicity compared to vancomycin ✔ Better patient tolerance ✔ Suitable for prolonged therapy ✔ Excellent tissue penetration ✔ Safe for outpatient therapy in some cases

SPINUM-1GM INJ contains Meropenem 1 gram, a powerful broad-spectrum carbapenem antibiotic used to treat moderate to severe bacterial infections, including infections caused by multidrug-resistant organisms. Meropenem is a broad-spectrum intravenous carbapenem antibiotic that works against a wide range of gram-positive, gram-negative, and anaerobic bacteria. It is known for its high stability against beta-lactamase enzymes, making it effective against many resistant bacterial strains. Benefits of SPINUM-1GM INJ ✔ Broad-spectrum coverage ✔ Rapid bactericidal action ✔ Effective against resistant organisms ✔ Excellent tissue penetration ✔ Suitable for severe infections ✔ Lower seizure risk compared to some carbapenems ✔ Widely trusted in critical care

POLYREST-INJ (Polymyxin-B Injection) is a potent, hospital-grade antibiotic used for the treatment of severe and life-threatening bacterial infections, particularly those caused by multidrug-resistant gram-negative organisms. It belongs to the polymyxin class of antibiotics and is often considered a last-line or reserve therapy when standard antibiotics fail to work. This medication is administered only under strict medical supervision due to its powerful action and the need for careful monitoring of kidney and neurological function. What is Polymyxin-B? Polymyxin-B is a cyclic polypeptide antibiotic that works by targeting the outer cell membrane of gram-negative bacteria. It binds to bacterial phospholipids, disrupts membrane integrity, and causes leakage of essential cellular components, leading to rapid bacterial death. Benefits of POLYREST-INJ ✔ Effective against multidrug-resistant bacteria ✔ Rapid bactericidal action ✔ Life-saving option in critical care settings ✔ Useful when other antibiotics fail ✔ Suitable for severe hospital-acquired infections